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Abstract
The present study examined beliefs about sleep, as measured by the Dysfunctional Beliefs and 
Attitudes about Sleep (DBAS) scale, as predictors of adherence to three specific insomnia 
treatment recommendations: restriction of time spent in bed, maintenance of a consistent rise time, 
and completion of daily meditation practice. Higher DBAS scores predicted poorer adherence to 
restriction of time spent in bed and to maintenance of a prescribed rise time. DBAS scores were 
not associated with completion of daily meditation. These preliminary findings suggest that pre-
treatment beliefs about sleep may impact patient engagement with behavioral recommendations 
regarding time in bed and consistent rise time during treatment for insomnia.
Cognitive-behavioral therapy for insomnia (CBT-I) has emerged as an efficacious treatment, 
achieving status as a standard treatment in published guidelines by the American Academy 
of Sleep Medicine (Morgenthaler et al., 2006). CBT-I is a multicomponent treatment 
package that includes stimulus control therapy (Bootzin, Epstein, & Wood, 1991) and sleep 
restriction therapy (Spielman, Saskin, & Thorpy, 1987) as the core behavioral components 
along with cognitive therapy aimed at challenging maladaptive sleep-related cognitions. 
Given that the efficacy of CBT-I has been established (Edinger, Wohlgemuth, Radtke, 
Marsh, & Quillian, 2001a; Edinger et al., 2009; Morin et al., 1999; Sivertsen et al., 2006), 
attention is now shifting to understanding factors related to the context and delivery of CBT-
I in an effort to optimize implementation in clinic settings and tailor treatment to meet 
specific patient needs.
Adherence to treatment is an important aspect of the context and delivery of CBT-I but there 
is no standard method for assessing adherence, and the identification of predictors of 
treatment adherence is particularly critical to the delivery of CBT-I in clinical settings. A 
limited number of studies have examined predictors of adherence to CBT-I in clinical trials 
and identified four potential predictors. First, several aspects of perceived behavioral 
control, including lower self-efficacy, are associated with poorer adherence to sleep hygiene 
instructions (Hebert, Vincent, Lewycky, & Walsh, 2010), as well as a lower composite 
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CBT-I adherence score (Bouchard, Bastien, & Morin, 2003). Second, depressive or 
dysthymic symptoms have been identified as obstacles to adherence, when operationalized 
as therapist-rated adherence (Vincent & Hameed, 2003), or self-reported adherence to 
behavioral recommendations (Manber et al., 2011; McChargue et al., 2012) and cognitive 
components such as changing expectations about sleep (Manber et al., 2011). Third, some 
evidence suggests that less severe insomnia prior to treatment initiation, as measured by 
better sleep quality and more sleepiness (potentially an indication of less hyperarousal) is 
predictive of lower session attendance rates (Morgan, Thompson, Dixon, Tomeny, & 
Mathers, 2003) and sleep diary-obtained inconsistency in rise time (Vincent, Lewycky, & 
Finnegan, 2008), respectively. Lastly, some studies have shown those with decreased 
readiness or motivation for change are more likely to report poorer adherence to sleep 
hygiene instructions (Hebert, Vincent, Lewycky, & Walsh, 2010) and report poorer 
adherence to rise time and time in bed recommendations in their sleep diary (Matthews, 
Schmiege, Cook, Berger, & Aloia, 2012). Other predictors of adherence (e.g. age, social 
support, medication use, and fewer perceived barriers to treatment) have been examined, but 
data for these predictors are inconclusive (Hebert, Vincent, Lewycky, & Walsh, 2010; 
Vincent, Lewycky, & Finnegan, 2008).
Maladaptive beliefs about sleep have been associated with response to CBT-I (Edinger, 
Wohlgemuth, Radtke, Marsh, & Quillian, 2001b; Morin, Blais, & Savard, 2002; Tremblay, 
Savard, & Ivers, 2009), but the relationship between sleep-related beliefs and adherence to 
treatment recommendations has not been previously explored. The Dysfunctional Beliefs 
and Attitudes about Sleep (DBAS) scale (Morin, 1993; Morin, Stone, Trinkle, Mercer, & 
Remsberg, 1993) is a widely used measure of sleep-related cognitions. It assesses thoughts 
that may serve to maintain or perpetuate insomnia and are therefore targeted in CBT-I. 
Conceptually, it is possible that maladaptive beliefs might serve as barriers to engagement 
and adherence to a variety of treatment recommendations including both sleep-related 
recommendations (such as restricting time in bed and maintaining a consistent rise time) and 
daytime recommendations (such as reducing hyperarousal) (Carney & Edinger, 2006).
Relaxation exercises are often used to complement sleep restriction or stimulus control as 
part of a multicomponent behavioral treatment for insomnia. Relaxation is viewed as an 
acceptable treatment approach for insomnia (Epstein, Babcock-Parziale, Haynes, & Herb, 
2012), and there is some evidence that adherence to relaxation exercises delivered with 
stimulus control is related to improvement in sleep quality (Lichstein, Wilson, & Johnson, 
2000). However, there has been little research on predictors of adherence to relaxation or 
other non-sleep-specific recommendations to reduce arousal. In our lab, we have been 
developing and testing the use of mindfulness meditation as a strategy to reduce sleep-
related arousal (Ong, Shapiro, & Manber, 2008). Mindfulness meditation is the practice of 
focusing on the present moment in a non-judgmental manner that is hypothesized to reduce 
sleep-related metacognitions involved in an insomnia disorder (Ong, Ulmer, & Manber, 
2012). In our treatment development study (Ong, Shapiro, & Manber, 2008), the traditional 
cognitive therapy component of CBT-I was replaced with mindfulness meditation and 
combined with sleep restriction and stimulus control. Even though the practice of formal 
meditation is a measurable behavior, there has been very little research related to adherence 
to meditation practice. One prospective study examining personality factors found that 
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short-term (3-month) adherence to meditation was related to low levels of baseline 
sensitization, introversion, suggestibility, and neuroticism while long-term (6- to 24-month) 
adherence was related only to repression and extraversion (Delmonte, 1988). To our 
knowledge, no study has examined the relationship between pre-treatment cognitions and 
adherence to mindfulness meditation practice. It might be the case that individuals who hold 
very strong beliefs about the causes and consequences of health issues, such as a sleep 
disturbance, might not be ready or willing to engage in meditation practice.
The aim of the present study was to provide preliminary insights into the impact of 
maladaptive beliefs about sleep on adherence to three behavioral recommendations in the 
treatment of insomnia: restricting time spent in bed, maintaining a consistent rise time, and 
engaging in mindfulness meditation. We hypothesized that stronger endorsement of 
maladaptive beliefs about sleep would be predictive of poorer adherence to prescribed time 
in bed, prescribed rise time, and daily sessions of meditation (mindfulness meditation). This 
study consists of secondary analyses to examine treatment process variables from a dataset 
obtained from a treatment development study of a mindfulness-based treatment for insomnia 
(Ong, Shapiro, & Manber, 2008).
Methods
Participants
Participants were recruited via flyers and electronic advertisements posted around Stanford 
University and the surrounding San Francisco Bay area. Eligible participants were adults 
(aged 18 to 65 years) who met International Classification of Sleep Disorders – Second 
Edition (ICSD-2) (American Academy of Sleep Medicine, 2005) criteria for a diagnosis of 
psychophysiological insomnia and recommended quantitative criteria for insomnia 
(Lichstein, Durrence, Taylor, Bush, & Riedel, 2003) defined as: (a) difficulty initiating or 
maintaining sleep or non-restorative sleep at least 3 nights per week; difficulty initiating 
sleep was defined as sleep onset latency greater than 30 minutes and difficulty maintaining 
sleep was defined as reporting total time wake after sleep onset (including early morning 
awakenings) greater than 30 minutes, (b) a complaint of daytime impairment or distress, (c) 
evidence of heightened arousal (e.g. inability to shut off mind, physical tension at bedtime), 
and (d) symptoms lasting for at least 1 month. Participants were excluded based on the 
presence of a previously diagnosed sleep disorder other than insomnia, an untreated mood, 
anxiety, or psychotic disorder, uncontrolled medical disorders, or use of alcohol within two 
hours of bedtime more than twice per week reported during the screening interview.
Of the 45 potential participants who responded to flyers and electronic advertisements, five 
failed to meet eligibility criteria, eight withdrew prior to treatment, and two qualified but 
failed to attend any intervention sessions. Thus, 30 participants (18 female) completed the 
screening process, qualified, and received the study intervention, representing an enrollment 
rate of 66.7%. Of those, 27 completed the protocol for a 10% attrition rate. Racial and ethnic 
distribution of the sample was as follows: 63% Caucasian, 17% Asian, 10% Hispanic, 3% 
African-American, and 7% participants who identified themselves as an “other ethnicity.” 
Average age of the sample was 36.4 years (SD = 14.1 years). Participants in the sample were 
well educated (mean years of education 16.6. years, SD=3.1 and all participants had at least 
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12 years of education). 60% of the sample was single. Finally, participants in the final 
sample reported chronic insomnia with an average duration of insomnia of 84.8 months 
(range of 1 month to 40 years, SD=109.0).
Treatment Protocol
The intervention was delivered in groups of 7-8 participants; each group met for 90-120 
minutes per week for 6 weeks. For a full description of the treatment protocol, see the 
treatment-development manuscript (Ong, Shapiro, & Manber, 2008). Table 1 provides a 
summary of treatment components. In brief, the multicomponent treatment combined 
stimulus control treatment, sleep restriction treatment, and sleep education with training in 
mindfulness meditation. Sleep restriction therapy is an iterative process that starts with 
reducing the time spent in bed to more closely match current total sleep time in order to 
improve sleep efficiency, and slowly expand the time in bed window as sleep efficiency 
increases (Spielman, Saskin, & Thorpy, 1987). In the version of sleep restriction therapy 
used in this study, the initial recommended time in bed was the average total sleep time at 
baseline plus 30 minutes. Stimulus control consists of extinguishing behaviors in bed that 
are incompatible with sleep and re-establishing the bed as a stimulus for sleepiness (Bootzin, 
Epstein, & Wood, 1991). The specific combined stimulus control and sleep restriction 
instructions were presented by encouraging participants to maintain a fixed rise time (i.e., 
prescribed rise time), to go bed only when sleepy, to avoid napping, and to use the bed for 
sleep and sex only. With respect to rise time, participants were instructed to set an alarm 
clock for the prescribed rise time. Sleep education included a lecture on sleep and wake 
processes, normative sleep requirements, and good sleep hygiene. Although this presentation 
may have indirectly addressed patient's beliefs about sleep, no formal cognitive therapy (e.g. 
cognitive restructuring) was included in this treatment protocol to address cognitions related 
to sleep restriction or stimulus control recommendations. Training in mindfulness meditation 
consisted of guided meditation exercises and instructions and materials for home practice. 
Patients were encouraged to complete at least five mindfulness meditation sessions per 
week, each lasting for at least 30 minutes.
Measures
Dysfunctional Beliefs and Attitudes about Sleep Scale (DBAS; Morin, Stone, 
Trinkle, Mercer, & Remsberg, 1993; Morin, 1993)—The DBAS is a 30-item self-
report questionnaire that assesses beliefs about consequences of insomnia, perceived lack of 
control over sleep, expectations regarding sleep, causes of insomnia, and sleep-promoting 
practices. Items are answered on a 10-point scale with higher scores representing a stronger 
endorsement of the specific maladaptive belief or attitude. Reliability and validity of the full 
measure has been previously documented (Carney & Edinger, 2006; Edinger, Carney, & 
Wohlgemuth, 2008; Espie, Inglis, Harvey, & Tessier, 2000). DBAS scores have been shown 
to decrease during cognitive-behavioral treatment for insomnia (Carney & Edinger, 2006), 
and higher dysfunctional beliefs have been shown to predict greater improvement following 
treatment with CBT-I (Edinger, Carney, & Wohlgemuth, 2008). In the present study, DBAS 
scores were analyzed as a potential predictor of treatment adherence.
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Insomnia Severity Index (ISI; Bastien, Vallieres, & Morin, 2001; Morin & Espie, 
2003)—The ISI contains seven self-report items that assess nighttime and daytime 
symptoms of insomnia over the past week using a 5-point Likert-type scale. The ISI has 
been used extensively as both a screening tool and outcome measure in insomnia research. 
The reliability and validity of the ISI have been previously documented (Bastien, Vallieres, 
& Morin, 2001). In the present study, pre-treatment ISI scores were used as covariates to 
statistically control for the impact of insomnia severity on treatment adherence.
Operationalization of Adherence—Given the difficulty in distinguishing treatment 
components within a multi-component package, the goal of this paper was to examine 
adherence to specific behavioral recommendations rather than specific treatment 
components (stimulus control or sleep restriction). All measures of adherence were derived 
from daily diaries for sleep and meditation practice. Daily sleep diaries are considered a 
standard practice in the assessment and treatment of insomnia (Carskadon et al., 1976) and 
provide a measure of the specific behavior targets of interest. Participants completed daily 
sleep diaries for the duration of the six-week treatment protocol. Participants recorded time 
they got into bed (bedtime), minutes to sleep onset, minutes of wake after sleep onset, time 
they woke, time they got out of bed (rise time), and total hours of sleep. From these daily 
sleep diary data, total time in bed was computed as the time from bedtime to rise time. 
Percent days of adherence to time in bed, was computed as the number of days when a 
participant's total time in bed was no more than 30 minutes longer than prescribed (out of a 
total of 35 days, no recommendations regarding sleep schedule were made in session 1). 
Percent days of adherence to rise time was computed as the number of days when a 
participant's rise time was no more than 60 minutes later than prescribed rise time (out of a 
total of 35 days, again no recommendations regarding sleep scheduling were made in 
session 1). Adherence to mindfulness meditation was computed from daily meditation 
diaries which were given after meditations were introduced in session 3. Participants were 
asked to record time and duration of each meditation session. Thus, percent days of 
adherence to meditation was computed as the number of days when a participant completed 
any amount of meditation (out of a goal of 20 days; patients were encouraged to complete at 
least 5 sessions per week for 4 weeks). There is no standard measure of adherence to 
meditation, but previous studies have computed adherence in a similar way, using the 
number of days when any amount of meditation was completed (Delmonte, 1984; Delmonte, 
1988).
Results
Preliminary Analyses
Overall, participants demonstrated moderate adherence to behavioral recommendations. On 
average, participants were in bed 22.0 minutes (SD=38.3 minutes) longer than prescribed, 
stayed in bed 30.5 minutes (SD=36.4 minutes) past the recommended rise time, and 
practiced mindfulness meditation on 17.7 days (SD = 7.9 days; out of a total of 28 possible 
days and a total of 20 recommended days). Participants were adherent with total time in bed 
recommendations 61.6% of days (SD = 27.4, range = 0 – 96.4%), adherent with rise time 
recommendations 72.4% of days (SD = 24.8, range = 17.1 – 100%), and adherent with 
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meditation on 63.4% of days (SD = 28.1, range = 0 – 100%). Weekly rates of adherence for 
each measure are presented in Table 2. There were no significant differences in rates of 
adherence across weeks. Pre-treatment DBAS scores were significantly negatively 
correlated with both percent days of adherence to total time in bed (r = -.45, p = .02) and 
percent days of adherence to rise time (r = -.64, p = .00) indicating that higher scores on the 
DBAS were associated with poorer adherence. Pre-treatment DBAS scores were not 
significantly correlated with percent days with meditation (r = .14, p = .48). Means, standard 
deviations, and bivariate correlations among total DBAS scores and the three measures of 
adherence were computed are presented in Table 3.
Preliminary regression analyses were performed to examine the association between each of 
the three measures of adherence to treatment (percent days of adherence to time in bed, 
percent days of adherence to rise time, and percent days with meditation) and each of the 
following participant characteristics: age, gender, ethnicity, years of education, duration of 
insomnia, and self-reported severity of insomnia (ISI scores). As there were no a priori 
hypotheses about these demographic and clinical variables, forward-entry selection (p <.05 
for entry) was used in the regression analyses. No demographic or clinical characteristics 
emerged as significant predictors of percent days of adherence to time in bed or percent days 
with meditation. However, insomnia severity emerged as a significant predictor of percent 
days of adherence to rise time (standardized β= -.40, t = -2.09, p = .05); demonstrating that 
those with more severe insomnia were less adherent to this recommendation. Insomnia 
severity was entered as a covariate in the first step of all subsequent regression analyses in 
which percent days of adherence to rise time was the dependent variable. Means, standard 
deviations, and bivariate correlations among ISI scores and the three measures of adherence 
are presented in Table 3.
Beliefs about Sleep and Adherence
To test the hypotheses that greater baseline (e.g. prior to treatment) maladaptive beliefs 
about sleep at bedtime would predict poorer adherence to time in bed, rise time, and 
meditation practice, hierarchical linear regression analyses were performed separately for (a) 
percent days of adherence to time in bed, (b) percent days of adherence to rise time, and (c) 
percent days with meditation as the dependent variable. The analyses for percent days 
adherence to time in bed and percent days with meditation included only total DBAS score 
as a predictor, as no demographic or baseline clinical characteristics (e.g. insomnia severity) 
emerged as significant correlates in the preliminary analyses. For the analysis for adherence 
to rise time, ISI scores were entered in the first step of a hierarchical linear regression 
analyses, and total DBAS score were entered on the second step, using forward-entry 
selection (p <.05 for entry). At each step of the model, the significance of the increment in 
R2 was tested. Significance level for all analyses was set at p <.05.
Total DBAS score (standardized β = -.45, t = -2.48. p = .02) was a significant predictor of 
percent days of adherence to time in bed. Specifically, higher DBAS scores were associated 
with lower adherence to time in bed recommendations, with participants spending more time 
in bed than prescribed. Total DBAS score (standardized β = -.60, t = -2.79, p = .01) was also 
a significant predictor of percent days of adherence to prescribed rise time after controlling 
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for insomnia severity. Specifically, higher DBAS scores were associated with lower 
adherence to rise time, with participants staying in bed later than prescribed (poorer 
adherence) regardless of insomnia severity. Total DBAS score (standardized β = .14, t = .71. 
p = .49) was not a significant predictor of percent days of meditation.
Discussion
In the present study, participants were adherent to the time in bed recommendation on 62% 
of the days, to the rise time on 72% of days, and to meditation practice on 63% of the days. 
Adherence was also relatively stable across weeks during the treatment study. These rates 
fall within the range of 42-90% reported in the literature using other operational definitions 
of adherence (Epstein, Sidani, Bootzin, & Belyea, 2012; Matthews, Schmiege, Cook, 
Berger, & Aloia, 2012; McChargue et al., 2012; Schoicket, Bertelson, & Lacks, 1988; 
Tremblay, Savard, & Ivers, 2009; Waters et al., 2003). While these findings suggest that 
participants were adherent to the treatment recommendations on the majority of days, it also 
suggests that adherence is suboptimal on approximately 30-40% of days during treatment, or 
about 2 to 3 days per week. When examining predictors of non-adherence, we found that 
greater maladaptive beliefs about sleep were associated with spending more time in bed than 
prescribed and rising later than prescribed. Beliefs about sleep were not associated with 
adherence meditation practice.
There are several possible explanations for the relationship between maladaptive beliefs 
about sleep and adherence to time in bed and rise time. One explanation is that a strong 
endorsement of maladaptive beliefs may decrease perceived efficacy and credibility of the 
treatments. For example, if patients are fused to the belief that they “need eight hours of 
sleep to feel refreshed and function during the day,” they may not perceive restriction of 
time in bed to less than eight hours as potentially effective and will therefore be reluctant to 
adhere. Similarly, if patients believe that if they “have difficulty getting to sleep, they should 
stay in bed and try harder,” it may be counter intuitive and very difficult for them to accept 
the rationale of using an alarm clock to maintain a consistent rise time.
A second explanation stems from literature examining Brehm's reactance theory (Brehm, 
1966) as an explanation for poor adherence. Reactance theory states that when an individual 
feels that behavioral freedoms are restricted and perceives limited control over behavior, he 
or she may engage in the restricted behaviors in order to reestablish a sense of control. It has 
been hypothesized that some patients engage in non-adherent behaviors (e.g. do the opposite 
of what they are prescribed to do) as an effort to reestablish as sense of control in the face of 
perceived loss of control (Cvengros, Christensen, & Lawton, 2004). During the course of 
treatment for insomnia, a patient may endorse perceived lack of control over sleep (e.g. a 
belief of that “I can't ever predict whether I will have a good or poor night's sleep”) and feel 
that behavioral freedom related to sleep is restricted (e.g. a therapist is dictating bedtime and 
rise times for the participant). As a result, a patient may resist treatment recommendations, 
such as staying in bed as late as they would like, as a way to reassert personal control over 
their sleep. Notably, scores on a measure of sleep-related locus of control (i.e. beliefs about 
ability to personally affect sleep and insomnia), perceptions of decreased control are 
associated with poorer treatment outcome (Vincent, Sande, Read, & Giannuzzi, 2004; 
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Vincent, Walsh, & Lewycky, 2010). However, it is important to consider the role of the 
therapeutic alliance with respect to reactance, as previous work has suggested that a positive 
patient-provider is associated with better adherence to treatment (Cvengros, Christensen, 
Cunningham, Hillis, & Kaboli, 2009). Perhaps a strong patient-therapist relationship may 
help a patient to “override” the urge to react with maladaptive behaviors in the face of 
perceived loss of control.
We did not find a relationship between sleep-related cognitions and adherence to meditation 
practice. One potential explanation for this finding is that even when negative beliefs about 
sleep are present, they are not directly related to the practice of meditation and therefore not 
likely to promote reactance or interfere with adherence to this treatment component. Another 
possibility for the non-significant finding is that meditation practice is not a sleep-related 
behavior per se and therefore might not have shared variance with the DBAS. It might be the 
case that metacognitions, rather than beliefs and attitudes about sleep, would yield a stronger 
relationship with the practice of mindfulness meditation.
The findings from this study should be considered preliminary and interpreted within the 
context of some limitations. First, this study was conducted as a secondary analysis of data 
from a treatment development study which included mindfulness meditation, a novel 
treatment component for insomnia. Although mindfulness meditation is not directed at 
changing sleep-related cognitions, it is possible that behavioral treatment components 
delivered in conjunction with mindfulness meditation may be perceived differently than 
behavioral treatment components delivered alone. Thus, the impact of maladaptive beliefs 
about sleep on adherence to treatment may not generalize to patients receiving standard 
CBT-I. Second, the generalizability of these findings is limited by the size and selection of 
the sample (e.g. small sample of highly educated patients). Third, this study used only self-
reported measures of adherence which may not accurately reflect patient behavior.
The above limitations not with standing, the results from this preliminary study suggest that 
pre-treatment beliefs about sleep may be related to patient adherence and patient 
engagement in non-pharmacological treatments for insomnia. Furthermore, the findings 
suggest the need for additional research that examines individual characteristics that may 
impact the course of treatment for insomnia. For example, future studies may examine the 
importance of directly addressing maladaptive beliefs about sleep, through formal cognitive 
restructuring, early in treatment for insomnia, perhaps even before the presentation of sleep 
restriction of stimulus control strategies. Correction of maladaptive beliefs may increase a 
patient's ability and self-efficacy to participate in behavioral components. Alternatively, 
future studies may examine the role of treatment matching (assigning patients to different 
treatments based on individual difference characteristics), treatment tailoring (modifying a 
single treatment based on specific beliefs), and adaptive treatments (providing additional 
treatment based on initial response to treatment) based on maladaptive beliefs about sleep.
In summary, to the best of our knowledge, this study is the first to directly examine the 
relationship between maladaptive beliefs about sleep and adherence to restricting time in 
bed, maintaining a consistent rise time, and practicing mindfulness meditation for insomnia. 
Despite the limitations, the results from this study highlight the interactive effects of the 
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cognitive and behavioral components in CBT-I and demonstrate the need for additional 
work examining potential predictors of adherence to insomnia treatment.
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Table 1
Treatment Components by Session
Session Treatment Components Adherence Target
1 Introduction and education and sleep and sleep hygiene No specific recommendations for sleep or meditation
2 Stimulus Control and Sleep Restriction Begin adherence to prescribed sleep schedules (time in bed and rise 
time)
3 Mindfulness and arousal Begin adherence to formal meditation practice at home; continue with 
prescribed sleep schedule
4 Adjusting sleep schedules, mindfulness practices Continue adherence to prescribed sleep schedules and meditation 
practice
5 Discuss sleep schedules, mindfulness practices, daytime 
functioning
Continue adherence to prescribed sleep schedules and meditation 
practice
6 Discuss relapse prevention, managing sleep schedule and 
maintaining home meditation practice
Continue adherence to prescribed sleep schedules and meditation 
practice
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